Benchmark Holdings Plc — Earnings Release 2021

Oct 18, 2021

FY 21 Results expected to be significantly ahead of market expectations

FY 21 Results expected to be significantly ahead of market expectations

Continued good momentum across all business areas

Benchmark, the aquaculture biotechnology business, is pleased to provide an update ahead of its full year results for the year ended 30 September 2021 which will be announced on 29th November 2021.

Following positive financial results in Q3 2021, the Company maintained this momentum in Q4 2021 and has delivered a stronger than expected trading performance across its three business areas driven by the Group’s continued strong commercial focus, disciplined cost control and further recovery in the Company’s end markets. The Group’s Advanced Nutrition business area has continued to deliver excellent year on year growth while the Group’s Genetics business area delivered a strong end to the year, and in the Group’s Health business area, the Company achieved its first revenues from its sea lice treatment, Ectosan® Vet and CleanTreat®; all business areas delivered above the Board’s expectations in September.

As a result, whilst still subject to audit, the Group's Adjusted EBITDA for FY21 is expected to be significantly ahead of the current market consensus which is £15.9m.

Trond Williksen, CEO, commented:

“We are pleased by the continuing momentum in the business, which reflects the benefits of our clear commercial focus, having streamlined the organisation, our continued disciplined approach to cost control and good demand for our products in our recovering markets.

“As a focused aquaculture biotechnology company with three strong business areas, we are well positioned to capture market opportunities and deliver profitable growth.”

Notice of Results and details of analyst / investor call

The Company will announce its full year results on 29 November 2021. Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a webcast for analysts and institutional investors on that day at 8:30am UK time. To register your interest, please contact benchmark@mhpc.com.

Enquiries

For further information, please contact:

Benchmark Holdings plc Tel: 020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD) Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

MHP Communications Tel: 020 3128 8990 / 8742

Katie Hunt, Reg Hoare, Alistair de Kare-Silver benchmark@mhpc.com